179 related articles for article (PubMed ID: 28343127)
1. Direct immobilization of manganese chelates on silica nanospheres for MRI applications.
Pálmai M; Pethő A; Nagy LN; Klébert S; May Z; Mihály J; Wacha A; Jemnitz K; Veres Z; Horváth I; Szigeti K; Máthé D; Varga Z
J Colloid Interface Sci; 2017 Jul; 498():298-305. PubMed ID: 28343127
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanospheres as highly efficient MRI contrast agents.
Taylor KM; Kim JS; Rieter WJ; An H; Lin W; Lin W
J Am Chem Soc; 2008 Feb; 130(7):2154-5. PubMed ID: 18217764
[No Abstract] [Full Text] [Related]
3. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.
Vivero-Escoto JL; Taylor-Pashow KM; Huxford RC; Della Rocca J; Okoruwa C; An H; Lin W; Lin W
Small; 2011 Dec; 7(24):3519-28. PubMed ID: 22069305
[TBL] [Abstract][Full Text] [Related]
4. Mn(II)-Conjugated silica nanoparticles as potential MRI probes.
Lalli D; Ferrauto G; Terreno E; Carniato F; Botta M
J Mater Chem B; 2021 Nov; 9(43):8994-9004. PubMed ID: 34585711
[TBL] [Abstract][Full Text] [Related]
5. Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging.
Niu D; Luo X; Li Y; Liu X; Wang X; Shi J
ACS Appl Mater Interfaces; 2013 Oct; 5(20):9942-8. PubMed ID: 24059807
[TBL] [Abstract][Full Text] [Related]
6. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
8. Porous Silica Nanospheres with a Confined Mono(aquated) Mn(II)-Complex: A Potential
Mallik R; Saha M; Mukherjee C
ACS Appl Bio Mater; 2021 Dec; 4(12):8356-8367. PubMed ID: 35005912
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.
Islam MK; Kim S; Kim HK; Kim YH; Lee YM; Choi G; Baek AR; Sung BK; Kim M; Cho AE; Kang H; Lee GH; Choi SH; Lee T; Park JA; Chang Y
Bioconjug Chem; 2018 Nov; 29(11):3614-3625. PubMed ID: 30383368
[TBL] [Abstract][Full Text] [Related]
10. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
11. Application and mechanism of manganese-coated caramelization nanospheres for active targeting in hepatobiliary tumors.
Qi Y; Li W; Fang J; Xiang Y; Zhu M; Zhang X; Ma X; Wang Q; Zhan J; Yu D
Nanomedicine (Lond); 2019 Nov; 14(22):2973-2985. PubMed ID: 31793384
[No Abstract] [Full Text] [Related]
12. Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging.
An L; Hu H; Du J; Wei J; Wang L; Yang H; Wu D; Shi H; Li F; Yang S
Biomaterials; 2014 Jul; 35(20):5381-5392. PubMed ID: 24703718
[TBL] [Abstract][Full Text] [Related]
13. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
[TBL] [Abstract][Full Text] [Related]
14. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
15. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres.
Shen D; Yang J; Li X; Zhou L; Zhang R; Li W; Chen L; Wang R; Zhang F; Zhao D
Nano Lett; 2014 Feb; 14(2):923-32. PubMed ID: 24467566
[TBL] [Abstract][Full Text] [Related]
16. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.
Ratzinger G; Agrawal P; Körner W; Lonkai J; Sanders HM; Terreno E; Wirth M; Strijkers GJ; Nicolay K; Gabor F
Biomaterials; 2010 Nov; 31(33):8716-23. PubMed ID: 20797782
[TBL] [Abstract][Full Text] [Related]
17. Mn(II)-monosubstituted polyoxometalates as candidates for contrast agents in magnetic resonance imaging.
Li Z; Li W; Li X; Pei F; Wang X; Lei H
J Inorg Biochem; 2007 Jul; 101(7):1036-42. PubMed ID: 17524483
[TBL] [Abstract][Full Text] [Related]
18. Manganese Complex of Ethylenediaminetetraacetic Acid (EDTA)-Benzothiazole Aniline (BTA) Conjugate as a Potential Liver-Targeting MRI Contrast Agent.
Islam MK; Kim S; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Kim TJ; Chang Y
J Med Chem; 2017 Apr; 60(7):2993-3001. PubMed ID: 28301142
[TBL] [Abstract][Full Text] [Related]
19. Manganese threonine chelate-a new enteric contrast agent for MRI: a pilot study on rats.
Luo Y; Yu H; Hu D; Li J; Hu X; Li Z; Shen Y
NMR Biomed; 2020 Jun; 33(6):e4293. PubMed ID: 32175654
[TBL] [Abstract][Full Text] [Related]
20. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
